MedTrace Logo

The Effects of Dexmedetomidine on cTnI and GP-BB in Patients Undergoing OPCABG

NCT03163693 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2017-05-23

No results posted yet for this study

Summary

The purpose of this study is to observe the impact of dexmedetomidine on Cardiac Troponin I and Glycogen Phosphorylase Isoenzyme BB in patients undergoing off-pump coronary artery bypass Grafting.

Conditions

  • Coronary Artery Bypass, Off-Pump

Interventions

DRUG

dexmedetomidine

receive dexmedetomidine 0.5 μg/kg

OTHER

normal saline

receive equal volume of normal saline

Sponsors & Collaborators

  • General Hospital of Ningxia Medical University

    lead OTHER

Principal Investigators

  • Zhu Di · General Hospital of Ningxia Medical University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03163693 on ClinicalTrials.gov